US39536G1058 - Common Stock
GreenLight Biosciences Holdings PBC
NASDAQ:GRNA (7/21/2023, 7:00:02 PM)
After market: 0.2995 0 (0%)0.2995
0 (-0.03%)
GreenLight Biosciences Holdings PBC operates as a biotechnology company, which makes ribonucleic acid (RNA) products for human therapies and agriculture. The company is headquartered in Lexington, Massachusetts and currently employs 262 full-time employees. The company went IPO on 2021-01-14. The firm has a cell-free ribonucleic acid (RNA) production platform for the discovery, development, and commercialization of products to promote healthier plants, foods, and people. The firm's cell-free biomanufacturing platform enables the making of complex biological molecules-nucleic acids, peptides, carbohydrates, and many others using fermentation. Its technology platform provides integrated discovery, design, and development of RNA-based products used in advanced pharma discovery to agriculture and human health. The company has developed two manufacturing processes, one for plant health (dsRNA) and one for human health (mRNA) that both rely on synthesis of RNA from RNA building blocks, enzymes, and deoxyribonucleic acid (DNA) templates. The firm's plant program includes the Colorado Potato Beetle Program-Calantha; Varroa Mite Program, and Powdery Mildew Complex.
GreenLight Biosciences Holdings PBC
29 Hartwell Avenue
Lexington MASSACHUSETTS
P: 16176168188.0
Employees: 262
Website: https://greenlightbiosciences.com/
LEXINGTON, Mass., July 24, 2023 (GLOBE NEWSWIRE) -- GreenLight Biosciences Holdings, PBC (NASDAQ: GRNA) (“GreenLight” or the “Company”) today announced...
Completion of Previously Announced Merger and Going Private Transaction Expected July 20, 2023
Completion of Previously Announced Merger and Going Private Transaction Expected July 20, 2023...
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
/PRNewswire/ -- Kaskela Law LLC announces that it is investigating GreenLight Biosciences Holdings (NASDAQ: GRNA) ("GreenLight") on behalf of the company's...
Here you can normally see the latest stock twits on GRNA, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: